Sponsors

Clinical trial recruitment source quality: what sites should measure

A guide for measuring recruitment source quality beyond lead volume, including responsiveness, prescreen fit, scheduled visits, and stalled leads.

Lead volume is only one part of recruitment performance. Source quality includes responsiveness, fit, prescreen completion, records readiness, and scheduled next steps.

In this guide

Key points

  • A high-volume source can still create poor site outcomes if leads are unresponsive or not reviewable.
  • Sponsors and sites get a clearer picture when they compare sources by movement through the workflow, not only by inquiry count.
  • Source quality reporting helps teams decide where to invest, adjust messaging, or change site support.

Separate volume from usefulness

A recruitment source can look successful when judged only by lead count. But sites need to know whether those leads are reachable, relevant, and likely to move through prescreening or scheduling.

Useful source reporting includes new leads, contacted leads, prescreen completion, likely-fit patients, records blockers, scheduled visits, and close reasons.

Measure response and follow-up health

Source quality is affected by both the source and the site workflow. A good source may still look poor if the site follows up too slowly or lacks enough context to contact patients effectively.

That is why reporting needs to show response speed, coordinator ownership, and stale-lead rates alongside source-level performance.

Use fit signals carefully

Early fit signals can help compare sources, but they are not final eligibility. They are operational indicators that help teams decide where review and follow-up may be most productive.

Sponsors can look for patterns: which sources create reviewable patients, which create missing-information loops, and which produce scheduled screening visits.

Turn source data into decisions

The point of source quality reporting is not to build a bigger dashboard. It is to decide what to change: campaign messaging, study criteria communication, site staffing, follow-up cadence, or records support.

A recurring source-quality review can make sponsor conversations more specific and reduce the guesswork around recruitment performance.

Connect source quality to the next investment

Source quality is useful only when it changes the next investment decision. A sponsor may keep a smaller source if it creates reviewable patients, reduce a high-volume source if it creates stale work, or adjust messaging when a channel attracts the wrong expectations.

The review should compare source performance against site follow-up health so teams do not blame the wrong part of the workflow. A good source can look weak when ownership is slow, and a weak source can look busy when volume hides low readiness.

Sources and editorial notes

Published .

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Aggregate study reporting

Sponsor portfolio

6 active studies482 inquiries18 research sites
Study APhase IIb

39 / 50 enrolled78%

Study BPhase III

74 / 120 enrolled62%

Study CPhase I

9 / 10 enrolled90%

Keep reading